View in EDS HTML Full Text PDF Full Text

A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses.

Saved in:
Bibliographic Details
Title: A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses.
Authors: Battisti P; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Ykema MR; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Kasal DN; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Jennewein MF; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Beaver S; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Weight AE; Institute for Antiviral Research, Utah State University, Logan, UT, United States., Hanson D; Infectious Disease Research Institute, Seattle, WA, United States., Singh J; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Bakken J; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Cross N; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Fusco P; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Archer J; Infectious Disease Research Institute, Seattle, WA, United States., Reed S; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Gerhardt A; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States., Julander JG; Institute for Antiviral Research, Utah State University, Logan, UT, United States., Casper C; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.; Department of Medicine, University of Washington, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, United States., Voigt EA; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.
Source: Frontiers in immunology [Front Immunol] 2025 Apr 29; Vol. 16, pp. 1569454. Date of Electronic Publication: 2025 Apr 29 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40364846
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Battisti+P%22">Battisti P</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Ykema+MR%22">Ykema MR</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Kasal+DN%22">Kasal DN</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Jennewein+MF%22">Jennewein MF</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Beaver+S%22">Beaver S</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Weight+AE%22">Weight AE</searchLink>; Institute for Antiviral Research, Utah State University, Logan, UT, United States.<br /><searchLink fieldCode="AU" term="%22Hanson+D%22">Hanson D</searchLink>; Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Singh+J%22">Singh J</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Bakken+J%22">Bakken J</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Cross+N%22">Cross N</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Fusco+P%22">Fusco P</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Archer+J%22">Archer J</searchLink>; Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Reed+S%22">Reed S</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Gerhardt+A%22">Gerhardt A</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Julander+JG%22">Julander JG</searchLink>; Institute for Antiviral Research, Utah State University, Logan, UT, United States.<br /><searchLink fieldCode="AU" term="%22Casper+C%22">Casper C</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.; Department of Medicine, University of Washington, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Voigt+EA%22">Voigt EA</searchLink>; Access to Advanced Health Institute (AAHI), formerly Infectious Disease Research Institute, Seattle, WA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Apr 29; Vol. 16, pp. 1569454. <i>Date of Electronic Publication: </i>2025 Apr 29 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40364846
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1569454
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1569454
    Titles:
      – TitleFull: A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Battisti P
      – PersonEntity:
          Name:
            NameFull: Ykema MR
      – PersonEntity:
          Name:
            NameFull: Kasal DN
      – PersonEntity:
          Name:
            NameFull: Jennewein MF
      – PersonEntity:
          Name:
            NameFull: Beaver S
      – PersonEntity:
          Name:
            NameFull: Weight AE
      – PersonEntity:
          Name:
            NameFull: Hanson D
      – PersonEntity:
          Name:
            NameFull: Singh J
      – PersonEntity:
          Name:
            NameFull: Bakken J
      – PersonEntity:
          Name:
            NameFull: Cross N
      – PersonEntity:
          Name:
            NameFull: Fusco P
      – PersonEntity:
          Name:
            NameFull: Archer J
      – PersonEntity:
          Name:
            NameFull: Reed S
      – PersonEntity:
          Name:
            NameFull: Gerhardt A
      – PersonEntity:
          Name:
            NameFull: Julander JG
      – PersonEntity:
          Name:
            NameFull: Casper C
      – PersonEntity:
          Name:
            NameFull: Voigt EA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 04
              Text: 2025 Apr 29
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1